跳至主要内容
临床试验/NCT01840813
NCT01840813已完成1 期

Intra-umbilical Injection of Misoprostol Versus Normal Saline in the Management of Retained Placenta: Intrapartum Placebo-controlled Trial

Hawler Medical University1 个研究点 分布在 1 个国家目标入组 46 人开始时间: 2011年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
46
试验地点
1
主要终点
delivery of placenta by medical intervention

研究概览

简要总结

Administration of intraumbilical misoprostol to women with retained placenta despite active management of third stage of labour reduces the need for manual removal of placenta and the amount of blood loss vaginally.

详细描述

Retained placenta (RP)is one of the complications of third stage of labour; it should be managed promptly as it may cause severe bleeding, infection, maternal morbidity and mortality .The current standard management of RP word wide, by manual removal aims to prevent these problems, but it is unsatisfactory method because it requires general anaesthesia in hospital, It is an invasive procedure with its own serious complications of bleeding, infection and genital tract injury. Umbilical vein injection of misoprostol is a simple, safe method and could be performed at the place of delivery .

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
15 Years 至 45 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • women having singleton pregnancy
  • 28 weeks of gestation or more delivered vaginally
  • prolongation of the third stage of labour (more than 30 min) following active management of third stage of labour

排除标准

  • Who refused to participate in the trial
  • Multiple pregnancies
  • Previous Caesarean Section
  • Haemodynamically unstable
  • Severe anaemia (haemoglobin less than 8gm/dl)
  • Chorioamnionitis

研究组 & 干预措施

Misoprostol

Active Comparator

4 misoprostol tablets (Misotac® 200 micrograms tablet) dissolved in 20 ml of normal saline injected to umbilical vein

干预措施: Misoprostol (Drug)

Normal saline

Placebo Comparator

Normal saline 0.9%, 20 ml was injected in the umbilical vein in cases of retained placenta

干预措施: Normal saline (Drug)

结局指标

主要结局

delivery of placenta by medical intervention

时间窗: 30 minutes after the injection of misoprostol or normal saline in the umbilical vein

The administration of intraumbilical misoprostol to women with retained placenta despite active management of third stage of labour reduces the need for manual removal of placenta under general anaesthesia.

次要结局

  • vaginal bleeding after misoprostol use(30 minutes after umbilical vein injection of misoprostol)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Assistant Prof. Shahla Alalaf

Assistant Professor

Hawler Medical University

研究点 (1)

Loading locations...

相似试验

进行中(未招募)
不适用
Misoprostol in the management of retained placenta, a safe alternative for manual removal? A randomised controlled trial. - Misoprostol in the management of retained placenta, a safe alternative for manual removal? A randomTo assess the effectiveness of misoprostol in the management of retained placenta. Will 800 micrograms of misoprostol orally reduce the need for manual removal under general anaesthesia and prove to be a safe alternative?MedDRA version: 8.1Level: HLTClassification code 10017847Term: Gastric ulcers and perforation
EUCTR2006-006371-20-NLMC100
尚未招募
不适用
Misoprostol in the management of retained placenta, a safe alternative for manual removal? A randomised controlled trial.Retained placenta
NL-OMON20129Giel van Stralen100
已完成
3 期
Misoprostol in the management of retained placenta, a safe alternative for manual removal? A randomised controlled trialretained placenta10010273
NL-OMON30364Academisch Medisch Centrum100
招募中
2 期
Comparison of the effect of intrauterine misoprostol administration with sublingual in second trimester abortions inductio
IRCT20130626013777N3Vice chancellor for Research,Tabriz University Of Medical Sciences86
已完成
不适用
Medical treatment of retained placenta: does it reduce the number of necessary surgical interventions? A randomised controlled trial in low resource settingRetained placentaPregnancy and ChildbirthRetained placenta and membranes
ISRCTN16104753Tanzanian German Programme to Support Health (TGPSH) (Tanzania)117